Antibodies to PhnD inhibit staphylococcal biofilms

Infection and Immunity

Volumn 82, Issue 9, 2014, Pages 3764-3774

  Lam, Hubert ^a   Kesselly, Augustus ^a   Stegalkina, Svetlana ^a   Kleanthous, Harry ^a   Yethon, Jeremy A ^a  

^a Sanofi Pasteur   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BACTERIUM ANTIBODY; ERYTHROMYCIN; KANAMYCIN; OPSONIN; POLYCLONAL ANTIBODY; TRIMETHOPRIM;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; BACTERIAL VIABILITY; BIOFILM; CATHETER INFECTION; CONTROLLED STUDY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMAGING SYSTEM; INTESTINE FLORA; INTRAVASCULAR CATHETER; MICROFLUIDICS; MONITORING; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SHEAR FLOW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; TIME-LAPSE VIDEO MICROSCOPY; VACCINATION;

ANTIBODIES; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOFILMS; HUMANS; NEUTROPHILS; PHAGOCYTOSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84906061862     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02168-14     Document Type: Article

References (40)

1. Centers for Disease Control and Prevention (CDC). 2011. Vital signs: central line-associated blood stream infections-United States, 2001, 2008, and 2009. MMWR Morb. Mortal. Wkly. Rep. 60:243-248.
2. Kilgore M, Brossette S. 2008. Cost of bloodstream infections. Am. J. Infect. Control 36:S172.e1-S172.e3. http://dx.doi.org/10.1016/j.ajic.2008.10.004.
3. Boyce JM. 2012. Prevention of central line-associated bloodstream infections in hemodialysis patients. Infect. Control Hosp. Epidemiol. 33:936-944. http://dx.doi.org/10.1086/667369.
4. Srinivasan A, Craig M, Cardo D. 2012. The power of policy change, federal collaboration, and state coordination in healthcare-associated infection prevention. Clin. Infect. Dis. 55:426-431. http://dx.doi.org/10.1093/cid/cis407.
5. Miller SE, Maragakis LL. 2012. Central line-associated bloodstream infection prevention. Curr. Opin. Infect. Dis. 25:412-422. http://dx.doi.org/10.1097/QCO.0b013e328355e4da.
6. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, Kallen A, Limbago B, Fridkin S. 2013. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect. Control Hosp. Epidemiol. 34:1-14. http://dx.doi.org/10.1086/668770.
7. Aldea-Mansilla C, Garcia de Viedma D, Cercenado E, Martin-Rabadan P, Marin M, Bouza E. 2006. Comparison of phenotypic with genotypic procedures for confirmation of coagulase-negative Staphylococcus catheter-related bloodstream infections. J. Clin. Microbiol. 44:3529-3532. http://dx.doi.org/10.1128/JCM.00839-06.
8. Haslett TM, Isenberg HD, Hilton E, Tucci V, Kay BG, Vellozzi EM. 1988. Microbiology of indwelling central intravascular catheters. J. Clin. Microbiol. 26:696-701.
9. Fey PD, Olson ME. 2010. Current concepts in biofilm formation of Staphylococcus epidermidis. Future Microbiol. 5:917-933. http://dx.doi.org/10.2217/fmb.10.56.
10. Van Mellaert L, Shahrooei M, Hofmans D, Eldere JV. 2012. Immunoprophylaxis and immunotherapy of Staphylococcus epidermidis infections: challenges and prospects. Expert Rev. Vaccines 11:319-334. http://dx.doi.org/10.1586/erv.11.190.
11. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. 2009. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49:1-45. http://dx.doi.org/10.1086/599376.
12. Kwasny SM, Opperman TJ. 2010. Static biofilm cultures of Grampositive pathogens grown in a microtiter format used for anti-biofilm drug discovery. Curr. Protoc. Pharmacol. 50:13A.18.1-13A.18.23. http://dx.doi.org/10.1002/0471141755.ph13a08s50.
13. Benoit MR, Conant CG, Ionescu-Zanetti C, Schwartz M, Matin A. 2010. New device for high-throughput viability screening of flow biofilms. Appl. Environ. Microbiol. 76:4136-4142. http://dx.doi.org/10.1128/AEM.03065-09.
14. Moormeier DE, Endres JL, Mann EE, Sadykov MR, Horswill AR, Rice KC, Fey PD, Bayles KW. 2013. Use of microfluidic technology to analyze gene expression during Staphylococcus aureus biofilm formation reveals distinct physiological niches. Appl. Environ. Microbiol. 79:3413-3424. http://dx.doi.org/10.1128/AEM.00395-13.
15. Augustin J, Gotz F. 1990. Transformation of Staphylococcus epidermidis and other staphylococcal species with plasmid DNA by electroporation. FEMS Microbiol. Lett. 54:203-207.
16. Hu J, Xu T, Zhu T, Lou Q, Wang X, Wu Y, Huang R, Liu J, Liu H, Yu F, Ding B, Huang Y, Tong W, Qu D. 2011. Monoclonal antibodies against accumulation-associated protein affect EPS biosynthesis and enhance bacterial accumulation of Staphylococcus epidermidis. PLoS One 6:e20918. http://dx.doi.org/10.1371/journal.pone.0020918.
17. Christner M, Franke GC, Schommer NN, Wendt U, Wegert K, Pehle P, Kroll G, Schulze C, Buck F, Mack D, Aepfelbacher M, Rohde H. 2010. The giant extracellular matrix-binding protein of Staphylococcus epidermidismediates biofilm accumulation and attachment to fibronectin. Mol. Microbiol. 75:187-207. http://dx.doi.org/10.1111/j.1365-2958.2009.06981.x.
18. Williams RJ, Henderson B, Sharp LJ, Nair SP. 2002. Identification of a fibronectin-binding protein from Staphylococcus epidermidis. Infect. Immun. 70:6805-6810. http://dx.doi.org/10.1128/IAI.70.12.6805-6810.2002.
19. Shahrooei M, Hira V, Khodaparast L, Khodaparast L, Stijlemans B, Kucharikova S, Burghout P, Hermans PW, Van Eldere J. 2012. Vaccination with SesC decreases Staphylococcus epidermidis biofilm formation. Infect. Immun. 80:3660-3668. http://dx.doi.org/10.1128/IAI.00104-12.
20. Shahrooei M, Hira V, Stijlemans B, Merckx R, Hermans PW, Van Eldere J. 2009. Inhibition of Staphylococcus epidermidis biofilm formation by rabbit polyclonal antibodies against the SesC protein. Infect. Immun. 77:3670-3678. http://dx.doi.org/10.1128/IAI.01464-08.
21. Otto M. 2012. Molecular basis of Staphylococcus epidermidis infections. Semin. Immunopathol. 34:201-214. http://dx.doi.org/10.1007/s00281-011-0296-2.
22. Arciola CR, Baldassarri L, Montanaro L. 2001. Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. J. Clin. Microbiol. 39:2151-2156. http://dx.doi.org/10.1128/JCM.39.6.2151-2156.2001.
23. Arciola CR, Gamberini S, Campoccia D, Visai L, Speziale P, Baldassarri L, Montanaro L. 2005. A multiplex PCR method for the detection of all five individual genes of ica locus in Staphylococcus epidermidis. A survey on 400 clinical isolates from prosthesis-associated infections. J. Biomed. Mater. Res. A 75:408-413. http://dx.doi.org/10.1002/jbm.a.30445.
24. Galdbart JO, Allignet J, Tung HS, Ryden C, El Solh N. 2000. Screening for Staphylococcus epidermidis markers discriminating between skinflora strains and those responsible for infections of joint prostheses. J. Infect. Dis. 182:351-355. http://dx.doi.org/10.1086/315660.
25. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29:996-1011. http://dx.doi.org/10.1086/591861.
26. Sellman BR, Howell AP, Kelly-Boyd C, Baker SM. 2005. Identification of immunogenic and serum binding proteins of Staphylococcus epidermidis. Infect. Immun. 73:6591-6600. http://dx.doi.org/10.1128/IAI.73.10.6591-6600.2005.
27. Hussain M, Herrmann M, von EiffC, Perdreau-Remington F, Peters G. 1997. A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect. Immun. 65:519-524.
28. Boles BR, Horswill AR. 2011. Staphylococcal biofilm disassembly. Trends Microbiol. 19:449-455. http://dx.doi.org/10.1016/j.tim.2011.06.004.
29. Wong CH, Jenne CN, Petri B, Chrobok NL, Kubes P. 2013. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat. Immunol. 14:785-792. http://dx.doi.org/10.1038/ni.2631.
30. Alicea I, Marvin JS, Miklos AE, Ellington AD, Looger LL, Schreiter ER. 2011. Structure of the Escherichia coli phosphonate binding protein PhnD and rationally optimized phosphonate biosensors. J. Mol. Biol. 414:356-369. http://dx.doi.org/10.1016/j.jmb.2011.09.047.
31. Jochimsen B, Lolle S, McSorley FR, Nabi M, Stougaard J, Zechel DL, Hove-Jensen B. 2011. Five phosphonate operon gene products as components of a multi-subunit complex of the carbon-phosphorus lyase pathway. Proc. Natl. Acad. Sci. U. S. A. 108:11393-11398. http://dx.doi.org/10.1073/pnas.1104922108.
32. Kamat SS, Williams HJ, Raushel FM. 2011. Intermediates in the transformation of phosphonates to phosphate by bacteria. Nature 480:570-573. http://dx.doi.org/10.1038/nature10622.
33. Metcalf WW, Wanner BL. 1993. Mutational analysis of an Escherichia coli fourteen-gene operon for phosphonate degradation, using TnphoA' elements. J. Bacteriol. 175:3430-3442.
34. Monds RD, Newell PD, Gross RH, O'Toole GA. 2007. Phosphatedependent modulation of c-di-GMP levels regulates Pseudomonas fluorescens Pf0-1 biofilm formation by controlling secretion of the adhesin LapA. Mol. Microbiol. 63:656-679.
35. Günther F, Wabnitz GH, Stroh P, Prior B, Obst U, Samstag Y, Wagner C, Hänsch GM. 2009. Host defence against Staphylococcus aureus biofilms infection: phagocytosis of biofilms by polymorphonuclear neutrophils (PMN). Mol. Immunol. 46:1805-1813. http://dx.doi.org/10.1016/j.molimm.2009.01.020.
36. Cerca N, Jefferson KK, Oliveira R, Pier GB, Azeredo J. 2006. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect. Immun. 74:4849-4855. http://dx.doi.org/10.1128/IAI.00230-06.
37. Rupp ME, Fey PD, Heilmann C, Gotz F. 2001. Characterization of the importance of Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the pathogenesis of intravascular catheterassociated infection in a rat model. J. Infect. Dis. 183:1038-1042. http://dx.doi.org/10.1086/319279.
38. Rupp ME, Ulphani JS, Fey PD, Mack D. 1999. Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model. Infect. Immun. 67:2656-2659.
39. Ebert T, Smith S, Pancari G, Wu X, Zorman J, Clark D, Cook J, Burns C, Antonello JM, Cope L, Nagy E, Meinke A, McNeely T. 2011. Development of a rat central venous catheter model for evaluation of vaccines to prevent Staphylococcus epidermidis and Staphylococcus aureus early biofilms. Hum. Vaccin. 7:630-638. http://dx.doi.org/10.4161/hv.7.6.15407.
40. Rasko DA, Sperandio V. 2010. Anti-virulence strategies to combat bacteria-mediated disease. Nat. Rev. Drug Discov. 9:117-128. http://dx.doi.org/10.1038/nrd3013.